Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis

NCT00782197 is registered in ClinicalTrials.gov with Biotechnology Institute IMASD as lead sponsor.

NCT NCT00782197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00782197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis
Lead sponsor
Biotechnology Institute IMASD
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
Not reported
Enrollment
240 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

joint disease